_PRIVATE_LIMITED.webp)
B. M. Pharmachem (India) Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 03-07-2024
- Paid Up Capital ₹ 2.50 M
as on 03-07-2024
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.70 Cr
as on 03-07-2024
- Satisfied Charges ₹ 4.80 M
as on 03-07-2024
- Revenue 11.92%
(FY 2021)
- Profit 34.36%
(FY 2021)
- Ebitda 11.34%
(FY 2021)
- Net Worth 6.95%
(FY 2021)
- Total Assets 1.68%
(FY 2021)
About B. M. Pharmachem (India)
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹1.70 Cr. The company has closed loans amounting to ₹4.80 M, as per Ministry of Corporate Affairs (MCA) records.
Nitishakumari Patel, Hilay Modi, and Heenaben Hajariwala serve as directors at the Company.
- CIN/LLPIN
U24239GJ2011PTC065322
- Company No.
065322
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 May 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does B. M. Pharmachem (India) Private Limited offer?
B. M. Pharmachem (India) Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, API Intermediate, Industrial Chemicals & Supplies, Inorganic Acids, Chemical Reagents & Catalysts, Bromine Compound, Iodine Compounds.
Who are the key members and board of directors at B. M. Pharmachem (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitishakumari Patel  | Director | 31-Aug-2022 | Current |
| Hilay Modi | Director | 31-Aug-2022 | Current |
| Heenaben Hajariwala | Director | 31-Aug-2022 | Current |
Financial Performance of B. M. Pharmachem (India).
B. M. Pharmachem (India) Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 11.92% increase. The company also saw a substantial improvement in profitability, with a 34.36% increase in profit. The company's net worth moved up by a moderate rise of 6.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of B. M. Pharmachem (India)?
In 2020, B. M. Pharmachem (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 22 Nov 2023 | ₹5.00 M | Open |
Dena Bank Creation Date: 02 Dec 2015 | ₹1.20 Cr | Open |
Vijaya Bank Creation Date: 22 Oct 2012 | ₹4.80 M | Satisfied |
How Many Employees Work at B. M. Pharmachem (India)?
B. M. Pharmachem (India) has a workforce of 1 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of B. M. Pharmachem (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped B. M. Pharmachem (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
